In an attempt to predict efficacy of CAR T cells targeting two or three GBM antigens, one study applied a binominal mathematical model, using expression of three of the well-described GBM-associated antigens, Her2, IL-13Rα2, and EphA2. This evidence concerns the gene EPHA2 and glioblastoma.